Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences
- DOI
- 10.34133/cancomm.0035
- Published
- 2026-01-01
- Container
- Cancer Communications
- Publisher
- American Association for the Advancement of Science (AAAS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.34133/cancomm.0035,
title = {Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences},
author = {Damien Bruyat and Nicolas Girard and Pierre Heudel and Nicolas Penel and Marie-Cécile Le Deley and Issaga Diallo and Jean-Marie Boher and Christophe Zemmour and Brice Chanez and Anne Madroszyk and Gwenaelle Gravis and Emilien Billon and Aaron Lisberg and Bérénice Collineau and Mathilde Beaufils and Anthony Gonçalves and Manuel Tejeda and Anne-Sophie Chrétien and Philippe Rochigneux},
year = {2026},
journal = {Cancer Communications},
doi = {10.34133/cancomm.0035},
url = {https://doi.org/10.34133/cancomm.0035}
}RIS
TY - JOUR TI - Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences AU - Damien Bruyat AU - Nicolas Girard AU - Pierre Heudel AU - Nicolas Penel AU - Marie-Cécile Le Deley AU - Issaga Diallo AU - Jean-Marie Boher AU - Christophe Zemmour AU - Brice Chanez AU - Anne Madroszyk AU - Gwenaelle Gravis AU - Emilien Billon AU - Aaron Lisberg AU - Bérénice Collineau AU - Mathilde Beaufils AU - Anthony Gonçalves AU - Manuel Tejeda AU - Anne-Sophie Chrétien AU - Philippe Rochigneux PY - 2026 JO - Cancer Communications DO - 10.34133/cancomm.0035 UR - https://doi.org/10.34133/cancomm.0035 ER -
APA
Bruyat, D., Girard, N., Heudel, P., Penel, N., Deley, M. L., Diallo, I., Boher, J., Zemmour, C., Chanez, B., Madroszyk, A., Gravis, G., Billon, E., Lisberg, A., Collineau, B., Beaufils, M., Gonçalves, A., Tejeda, M., Chrétien, A., & Rochigneux, P. (2026). Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences. Cancer Communications. https://doi.org/10.34133/cancomm.0035
Source records
- crossref · retrieved 2026-09-27T02:39:47.305Z